Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors

Oncotarget. 2017 Nov 3;8(59):99207-99208. doi: 10.18632/oncotarget.22276. eCollection 2017 Nov 21.

Authors

Elizabeth Allen¹, Rindert Missiaen¹, Gabriele Bergers¹

Affiliation

¹ Gabriele Bergers: Department of Oncology, Laboratory of Tumor Microenvironment and Therapeutic Resistance, VIB-Center for Cancer Biology, Katholieke Universiteit Leuven, Leuven, Belgium.

No abstract available

Keywords: antiangiogenic therapy; cancer; high-endothelial venules; immunotherapy; lymphotoxin-beta receptor.

Publication types

Editorial